Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Mar 29, 2022 1:23am
163 Views
Post# 34554307

RE:RE:RE:RE:RE:RE:RE:RE:RE:Snooze Fest

RE:RE:RE:RE:RE:RE:RE:RE:RE:Snooze FestYou may not be, I am. It's another milestone the company has repeatedly said they're working on as a high priority item and have failed to deliver. If it takes the simplest of tasks years to complete it's no wonder why everything else is taking so long. Conformal update. Thyroid update. Pharma collaboration update. Hemo update. Deal update. Patient 7 update. Age X update. They'll be needing to raise capital in a couple years time.
Redbaron2211 wrote: 3 more days.  This point I question again what is the reason we haven't seen a listing.  Could it be that we haven't shown an advanced stage of development or commercialization?   Does this validation come on a licensing deal? 

Given Philip saying we were well through the process of up-lising and the 4-6 week time frame you were given, it's safe to assume the process ran its course and either we will see it very soon or they were turned down pending something like a licensing deal. 

Either way when it comes down to it none of us are waiting on a TSX uplist.    


<< Previous
Bullboard Posts
Next >>